Other languages Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Delayed Nasdaq Other stock markets 01:27:30 22/06/2024 am IST			5-day change	1st Jan Change
8.45 ^USD	+1.81%		-10.48%	-55.00%

13/06	BMO Capital Raises Price Target on Scholar Rock to $31 From $29, Maintains Outperform Rating	MT
13/06	Transcript : Scholar Rock Holding Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 09:20 AM

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scholar Rock Reports 'Encouraging' Phase 1 Trial Results in Advanced Solid Tumors	04/06
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology Annual Meeting	28/05
Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity	22/05
Scholar Rock Holding Corporation Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity	22/05
Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss	07/05
Scholar Rock Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Scholar Rock Shares Rise After Raymond James Initiates Coverage	29/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Scholar Rock Announces Management Appointments	15/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01
Adipositas-Mittel führen zu Muskelverlust - Pharmafirmen steuern gegen	22/01
Scholar Rock Holding Insider Sold Shares Worth $448,444, According to a Recent SEC Filing	16/12
Scholar Rock Holding Insider Sold Shares Worth $436,820, According to a Recent SEC Filing	09/12
Scholar Rock Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Scholar Rock Holding Insider Sold Shares Worth $438,039, According to a Recent SEC Filing	06/11
Scholar Rock's Experimental Drug Shows Anti-Tumor Activity in Early-Stage Trial	04/11
Scholar Rock, Inc. Presents New Data from Phase 1 Dragon Trial Showing Promising Anti-Tumor Activity in Anti-Pd-1 Resistant Metastaticcc Patients and Supporting Srk-181 Continued Tolerability	04/11
Scholar Rock Announces to Present Clinical and Biomarker Data from the Phase 1 Dragon Trial At the Sitc 38Th Annual Meeting	19/23/19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Other languages

Filters